B2TJ82 AF NFT

6,7-dimethyl-8-ribityllumazine synthase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeifav6cfg45oc7jlyw6vtqviriy5t6x65qssh4w55wxwlmrrjoykcy/metadata.json
IPFS of structure file: 
bafybeidv7z352cqpokedql7aaroj7geoottwt7sx62sj2fnmw3ujcvpqwu/AF-B2TJ82-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x15142C148aC093E92d298118b2aFbDd91F151607
First NFT owner address (bech32): 
genesis1z52zc9y2czf7jtffsyvt9taamy0329s8fxuxly
Current NFT ID #346436 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
346436
Accession (UniProt):
B2TJ82
Name::
6,7-dimethyl-8-ribityllumazine synthase
Experimental Method:
Predicted structure
Sequence source:
Clostridium botulinum (strain Eklund 17B / Type B)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT B2TJ82 research and analysis (ICN3D with VR)

FASTA sequences

>sp|B2TJ82|RISB_CLOBB 6,7-dimethyl-8-ribityllumazine synthase OS=Clostridium botulinum (strain Eklund 17B / Type B) OX=935198 GN=ribH PE=3 SV=1 MNIFEGKLIAEGLKVGIIVGRFNEFIGSKLLDGALDGFKRHGVNVEDIDVAWVPGAFEMPLIAKKMAKSPKYDAVICLGAVIKGSTSHYDYVCSEVSKGIANVSLETGKPVMFGVLTTNNIEQAIERAGTKAGNKGYECAVGAIEMANLIKEL